Immunosuppression Articles & Analysis
31 articles found
Research efforts now focus on designing next-generation inhibitors with improved selectivity, tissue penetration, and minimal immunosuppressive effects. In parallel, gene-editing strategies and siRNA therapeutics targeting mutant ELANE alleles are being explored for hereditary neutropenia syndromes. ...
The IP10-loaded platelets targeted and inhibited tumor cells in the B16F10 melanoma model and lessened immunosuppressive regulatory T cell activity through CD40L activation on platelet membranes which led to boosted anti-tumor immunity. ...
Cytokines not only enhance the expansion and persistence of CAR-T cells, but also enhance their function in immunosuppressive TME. Cytokines, including interleukins, tumor necrosis factor, interferons, chemokines, colony-stimulating factors, growth factors, etc., are involved in the activation, proliferation, differentiation and survival of various immune cells. ...
Its primary function revolves around converting extracellular ATP into immunosuppressive adenosine, working in tandem with CD39 within normal tissues to curtail excessive immune reactions. ...
Patients at risk for invasive fungal infections include severely ill patients, immunosuppressed patients, patients after surgery, and patients using central venous catheters. ...
Reduced CADM1 expression may lead to the dampening of immune cell responses, limiting their ability to identify and attack cancer cells effectively. Immunosuppressive Microenvironment: Tumors can create an immunosuppressive microenvironment that hinders immune responses. CADM1 may be involved in modulating the immune cell composition within the tumor ...
In addition to its inhibitory effect on T cells, B7-H3 also suppresses NK cell activity. The immunosuppressive microenvironment shaped by B7-H3 helps cancer cells avoid immune destruction. [2] Strategies for Targeting B7-H3 in Immunotherapy The advantages of developing targeted drugs against B7-H3 in immunotherapy are as follows: (1) B7-H3 is expressed in most tumors, and ...
It can inhibit DC differentiation and antigen presentation, induce B cell apoptosis, inhibit effector T cell proliferation, and play an immunosuppressive role. Its carboxy-terminal FRED is the functional domain of its immunosuppressive activity. ...
The signaling biochemistry of these receptors is almost identical to that of PD-1, the same immunosuppressive receptor, but they do not bind to PD-L1, but to sugars. Bertozzi's team developed an anti-HER2 antibody around glycans that binds to sialase, which binds to these sugars on the surface of cancer cells, allowing the immune system to recognize and attack the cancer cells. ...
Studies over recent years have demonstrated that tumor initiation and progression are often mediated by the ability of the tumors to produce immunosuppressive proteins and activate immunosuppressive pathways, called immune checkpoint inhibitors (ICPI), that allow tumor growth and progression by shutting off these critical anti-tumor immune responses. ...
In the road of "killing enemies", the immunosuppressive microenvironment of the body gradually depletes reinfused T cells and cannot proliferate and survive for a long time. ...
However, the impact on solid tumors has been far below the expectations set in hematologic malignancies, largely due to the immunosuppressive nature of the tumor microenvironment. This approach, with Dr. ...
When gerbils are injected with non-steroidal immunosuppressive agents (tacrolimus), auto-infection can be carried out in their bodies. ...
Researcher Conejo-Garcia said that given that OR2H1 can be expressed in a variety of histological solid tumor subtypes (including high-grade serous ovarian cancer, lung adenocarcinoma, cholangiocarcinoma, prostate cancer and ovarian cancer with other histological characteristics, etc.), the results of this study confirm that this novel therapy may have some applicability to patients with a ...
SIGLECs, MGL, DC-SIGN) to induce immunosuppressive signals. There are various therapeutic approaches involving TACA, including vaccine-induced active immunity, as well as genetically engineered development of monoclonal antibodies. ...
T-cell responses could be improved further by administering low doses of gemcitabine, a chemotherapeutic drug that lowers immunosuppression. This treatment reduced the size of pancreatic tumors in mice by an average of 80% and cancer metastasis by 87%, and treated mice lived 40% longer than untreated mice. ...
However, under certain conditions (e.g., long-term immunosuppression), it can attack multiple organs and systems and cause severe disease. ...
Interleukin-10 (IL-10) IL-10, also known as cytokine synthesis inhibitory factor, is a typical anti-inflammatory and immunosuppressive cytokine produced mainly by activated monocytes and macrophages. ...
Tumors include not only cancer cells but also extracellular matrix (ECM), stromal cells (e.g., fibroblasts and mesenchymal stromal cells), vascular networks and immune cells such as T and B cells, NK cells, and various immunosuppressive cells such as tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), all of which constitute the tumor ...
It is easily removable and does not require any immunosuppressive treatment because of its nonbiological nature. Conclusions: Implantation of the EndoArt led to rapid corneal deturgescence and CCT restoration, presenting a possible option for patients with chronic corneal edema. ...